Your Source for Life Science Knowledge
DIA NOW is your comprehensive, personalized resource for the latest trends and up-to-the-minute updates on a wide variety of critical issues in the Life Sciences arena.
Access recorded sessions from the more than 60 global meetings taking place around the world annually, and breaking news and analysis from DIA’s publishing group.
Learn more about DIA NOW
DIA NOW Enterprise For groups of 50 or more
Watch DIA NOW in Action
Pricing varies based on number of users. Contact us for more information.
Coverage and Content
Access thousands of videos, podcasts and publications spanning the drug development life cycle.
Featured Content Previews
Clinical Development & Operations
FDARA Section 504 eliminated the orphan exemption for pediatric studies for cancer drugs and instead empowers the FDA to require pediatric assessments of new therapies.
Patient engagement initiatives are shown to increase chances of regulatory approval and accelerate development timelines.